Centre creating 'artificial scarcity' of COVID vaccines to benefit Bharat Biotech, SII: AAP
The AAP on Friday alleged that the Centre is creating "artificial scarcity" of COVID-19 vaccines to benefit Bharat Biotech and Serum Institute of India, a charge termed by the Delhi BJP as "unfounded". Addressing a press conference, AAP spokesperson Atishi said the government's vaccine drive has stopped in schools and this is the case throughout the country while in private hospitals, vaccination is still going on at different rates. India is currently using mainly two 'made-in India' jabs â Covishield manufactured by the Serum Institute and Covaxin of Bharat Biotech â and Russia...